Skip to Main Content
Our Commitment to Diversity

REPRESENTATIVE EXPERIENCE

Joshua Berick

M&A and Private Equity

Advised Shields Health Solutions LLC in connection with the US$1.37 billion acquisition by Walgreens Boots Alliance (NASDAQ: WBA) of the remaining 30% interest in Shields not previously held by it.
Advised the Fonds de solidarité FTQ and Caisse de dépôt et placement du Québec (CDPQ) in their acquisition of 65% of Bonduelle Americas Long Life.
Advised Solmax on its acquisition of Propex.
Advised Solmax on its €435 million acquisition of TenCate Geosynthetics Holding B.V. from Koninklijke Ten Cate B.V.
Advised Cypress Group Holdings on its US$125 million acquisition by Milestone Partners.
Advised EagleTree Capital on its US$525 million acquisition of Corsair Gaming from Francisco Partners.
Advised a Canadian real estate developer on its CA$528 million acquisition of the Canadian division of an international real estate developer.
Advised Corsair Gaming, Inc. on its acquisitions of SCUF Gaming, Origin PC, and the gaming division of Elgato Systems.
Advised a leading telecommunications company on the sale of its cloud and managed hosting service business.
Advised Royalty Pharma on its US$260 million acquisition of the royalty interest held by Arteaus Therapeutics in Eli Lilly and Company's EMGALITY®.
Advised a French biopharmaceutical company on its acquisition by a developer of novel treatments for endocrine diseases.
Advised a French venture capital fund focused on early- and mid-stage biotech and medtech start-ups on the reverse merger of a developer of novel treatments for endocrine diseases with a US publicly traded biotechnology company.
Advised Solmax on its US$250 million acquisition of GSE Environmental from Littlejohn & Co. and Strategic Value Partners.
Advised the Special Committee of the Board of Directors of American Realty Capital -- Retail Centers of America on its US$1.4 billion merger with American Finance Trust.
Advised The Depository Trust & Clearing Corporation on the sale of its Clarient and Avox businesses to Thomson Reuters.

Growth Equity and Venture Capital

Advised Creadev, Grosvenor Food & AgTech, and InvestEco in their participation in a Series B-1 Financing of Global Village Fruit d/b/a Jack & Annie’s.
Advised LKQ Corporation on its participation in the US$30 million Series A financing of Princeton NuEnergy.
Advised Creadev International on its participation in the US$14 million Series B financing round of Salted Inc.
Advised Creadev International on its participation in the US$25 million Series C-2 financing of Everytable PBC.
Advised Creadev International in its Series A investment in Rocket Health Africa Corporation, a provider of telemedicine and last-mile health care delivery services in East Africa.
Advised Creadev International in connection with its participation in a US$40 million Series C offering by Alira Health Group Holdings LLC.
Advised a French venture capital fund on its investment in a leading AR-powered remote visual support platform for enterprise field service and customer service.
Advised an Italian energy group on its investment in a company that aims to accelerate the industrial application of magnetic confinement fusion.
Advised a leading global investment management firm on early-stage investments in a number of digital health, biopharmaceutical, and technology companies.

Joint Ventures and other Strategic Transactions

Advised EagleTree Capital on the US$238 million initial public offering by its portfolio company, Corsair Gaming.
Advised GE Healthcare on its strategic partnership with Roche.
Advised GE Healthcare on its collaboration with Preventice Solutions.
Advised StepStone Group on its real estate development joint venture with Milhaus.
Advised McArthurGlen Europe on its €435 million European designer outlet center joint venture with Simon Property Group.
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel